ICMR has recommended hydroxychloroquine as a preventive medication for healthcare workers involved in care of suspected or confirmed cases of COVID-19 and also asymptomatic household contacts of laboratory confirmed cases  The Union health ministry has restricted the sale and distribution of ' hydroxychloroquine ' stating it as an essential drug to meet the requirements of any emergency arising due to COVID-19 pandemic .
The order issued on Thursday said that in public interest , it was necessary and expedient to regulate and restrict the sale and distribution of the drug and preparation based thereon for preventing misuse .
" The Central government is satisfied that the drug ' hydroxychloroquine ' is essential to meet the requirements of emergency arising due to pandemic COVID-19 and in the public interest , it is necessary and expedient to regulate and restrict the sale and distribution of the drug and preparation based thereon for preventing their misuse , " it said .
" Now , therefore , in exercise of the powers conferred by Section 26B of the Drugs and Cosmetics Act , 1940 ( 23 of 1940 ) , the Central Government hereby directs that sale by @ @ @ @ @ @ @ @ @ @ in accordance with the conditions for sale of drugs specified in Schedule H1 to the Drugs and Cosmetics Rules , 1945 , " it stated .
This order shall come into force on the date of its publication in the official gazette .
ICMR has recommended the use of hydroxychloroquine as a preventive medication for healthcare workers involved in the care of suspected or confirmed cases of COVID-19 and also asymptomatic household contacts of laboratory confirmed cases .
The treatment protocol recommended by the ICMR has been approved by the Drug Controller General of India ( DGCI ) for restricted use in emergency situations .
